Life Sciences Products and Contract Services

Not Disclosed, CO

Colorado Front Range

Asking Price: Annual Revenue:
$1,500,000 $583,113

Services: Non-classifiable

Request More Information
Contact the Seller

RE: Life Sciences Products and Contract Services Broker: Rob Amerine
License #: ER000212091

Quick Facts

Asking Price: $1,500,000
Annual Revenue: $583,113
Net Profit: Not Disclosed
Cash Flow: $583,113
Total Debt: Not Disclosed
FF&E: $297,000
Real Estate: Not Disclosed
Year Established: 2000
Employees: 8
BBN Listing #: 9072981
Broker Reference #: 1517

Email, Print & Share

Request More Information
Contact the Seller

Business Overview:

This life sciences contract research service company was founded in 2000 and is a key player in stem cell assay market. The company has developed patented and proprietary tests for in vitro toxicology testing of new drug candidates developed by biopharmaceutical companies. All of these tests and many others have been further developed for in-house testing for stem cell and veterinary research, cellular therapy and regenerative medicine and toxicology and sold as testing kits worldwide. This business is ready for new ownership to leverage its existing industry relationships and further profit by fully scaling the distribution of its many product lines. As of September 2019, gross sales have nearly doubled and SDE is nearly $250,000. The owner is looking to retire but can be a consultant for a limited period of time to help in a successful transition of the intellectual property and all in-house lab procedures. Gross Sales and SDE reflect a 5-year average.

To request more information regarding this listing, simply check the ADD TO REQUEST INFO BASKET button and when you are done searching and have made all your selections, simply click on the REQUEST INFO button at the bottom of the page.

Property Features and Assets:

4,400 Square Feet (approximate) leased facility.

Market Competition and Expansion:

- Increase current marketing efforts and add direct sales team with biopharmaceutical experience. - Expand the line of contract research services beyond the current target industries. - Focus on animal studies, including offering services to veterinarian clinics. - Focus on pharmaceutical companies in the early phase of drug development. - Direct marketing to help educate the U.S. stem cell transplant community based on U.K. trends.

Reason for Selling:


Additional Details:

  • The property is leased.
  • The owner is willing to train/assist the new owner.
  • This is not a homebased business opportunity.
  • This is not a franchise resale opportunity.

Relevant Links:

Request More Information
Contact the Seller is one of the largest business for sale marketplaces in the world that connects tens-of-thousands of business buyers and sellers every month. Sell a Business Online or if you’re a broker or a commercial agent sign up for a Business Broker Membership today!